February 2026 Philips expanded its wearable patient monitoring portfolio with AI-powered biosensors designed for continuous vital sign monitoring in hospital and home healthcare settings. The solutions support early intervention and improved clinical outcomes.
October 2025 Dexcom introduced upgraded wearable glucose monitoring systems featuring improved sensor accuracy, longer wear time, and enhanced smartphone connectivity. The innovations strengthen personalized diabetes management and remote care.
August 2025 Abbott expanded its FreeStyle Libre portfolio with advanced digital health integration and remote patient monitoring capabilities. The enhancements enable healthcare professionals and patients to access more comprehensive glucose monitoring data.
May 2025 Medtronic expanded its wearable healthcare portfolio by introducing next-generation continuous glucose monitoring (CGM) solutions with enhanced connectivity and real-time health insights. The devices improve diabetes management through continuous remote monitoring and AI-enabled data analysis.